Topical Ruxolitinib for Chronic Cutaneous GvHD: Promising Results of a Phase 2 Clinical Trial

被引：0
|
作者：
Markova, Alina [1 ]
Papadopoulos, Esperanza B. [2 ]
Dusza, Stephen [1 ]
Ostojic, Jelena [3 ]
Ai, Rizi [3 ]
Maier, Tara [1 ]
Lacouture, Mario [1 ]
Tamari, Roni
Gyurkocza, Boglarka
Shaffer, Brian C. [2 ]
Scordo, Michael [2 ]
Perales, Miguel-Angel [2 ]
Harris, Andrew [4 ]
Ponce, Doris M. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplantat Serv, New York, NY USA
[3] DermTech, San Diego, CA USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pediat, Pediat Stem Cell Transplantat & Cellular Therapie, New York, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182198
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Co-stimulated Th2 cells for modulation of acute GVHD: Phase I clinical trial results.
    Fowler, DH
    Odom, D
    Castro, K
    Kasten-Sportes, C
    Gea-Banacloche, J
    Dean, RM
    Wilson, W
    Foley, J
    Hou, J
    Hakim, F
    Leitman, S
    Read, EJ
    Carter, C
    Levine, B
    June, CH
    Gress, RE
    Bishop, MR
    BLOOD, 2002, 100 (11) : 214A - 214A
  • [22] A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease
    Sweet, Kendra
    Hazlehurst, Lori
    Sahakian, Eva
    Powers, John
    Nodzon, Lisa
    Kayali, Fadi
    Hyland, Kelly
    Nelson, Ashley
    Pinilla-Ibarz, Javier
    LEUKEMIA RESEARCH, 2018, 74 : 89 - 96
  • [23] Ruxolitinib: An effective JAK1/2 inhibitor in salvage therapy of refractory chronic GVHD
    Simonet, Marion
    Berceanu, Ana
    Daguindau, Etienne
    Desbrosses, Yohan
    Deconinck, Eric
    Larosa, Fabrice
    BONE MARROW TRANSPLANTATION, 2019, 54 : 320 - 320
  • [24] Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
    Jagasia, Madan
    Perales, Miguel-Angel
    Schroeder, Mark A.
    Ali, Haris
    Shah, Nirav N.
    Chen, Yi-Bin
    Fazal, Salman
    Dawkins, Fitzroy W.
    Arbushites, Michael C.
    Tian, Chuan
    Connelly-Smith, Laura
    Howell, Michael D.
    Khoury, H. Jean
    BLOOD, 2020, 135 (20) : 1739 - 1749
  • [25] TOPICAL THERAPY OF ACNE WITH TRETINOIN RESULTS OF A CLINICAL TRIAL
    ECKSTEIN, E
    STEINER, H
    WESENBERG, W
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1974, 24 (08): : 1205 - 1209
  • [26] Efficacy and safety of topical janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis: Results of a phase IIA randomized clinical trial
    Ports, William
    Bolduc, Chantal
    Papp, Kim
    Lamba, Manisha
    Bissonnette, Robert
    Khan, Shahbaz
    Lan, Shuping
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB199 - AB199
  • [27] Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial
    Jain, Preetesh
    Keating, Michael
    Renner, Sarah
    Cleeland, Charles
    Huang Xuelin
    Gonzalez, Graciela Nogueras
    Harris, David
    Li, Ping
    Liu, Zhiming
    Veletic, Ivo
    Rozovski, Uri
    Jain, Nitin
    Thompson, Phillip
    Bose, Prithviraj
    DiNardo, Courtney
    Ferrajoli, Alessandra
    O'Brien, Susan
    Burger, Jan
    Wierda, William
    Verstovsek, Srdan
    Kantarjian, Hagop
    Estrov, Zeev
    LANCET HAEMATOLOGY, 2017, 4 (02): : E67 - E74
  • [28] Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: Results of the phase III clinical trial
    Heald, P
    Mehlmauer, M
    Martin, AG
    Crowley, CA
    Yocum, RC
    Reich, SD
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (05) : 801 - 815
  • [29] Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD
    Wolff, Daniel
    Gerbitz, Armin
    Ayuk, Francis
    Kiani, Alexander
    Hildebrandt, Gerhard C.
    Vogelsang, Georgia B.
    Elad, Sharon
    Lawitschka, Anita
    Socie, Gerard
    Pavletic, Steven Z.
    Holler, Ernst
    Greinix, Hildegard
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (12) : 1611 - 1628
  • [30] SAFETY OF RUXOLITINIB IN PATIENTS WITH POLYCYTHEMIA VERA: RESULTS FROM THE CLINICAL TRIAL PROGRAM
    Verstovsek, S.
    Mesa, R.
    Martino, B.
    Kiladjian, J. -J.
    Jones, M. M.
    He, S.
    Habr, D.
    Alecu, I.
    Vannucchi, A. M.
    HAEMATOLOGICA, 2015, 100 : 263 - 264
12345